SCHEMBL7499501

SCHEMBL7499501

CCCSc1nc(Br)c(C=O)n1Cc1cc2c(cc1Cl)OCO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
EDNRA P25101 1/20 0.40
HSP90AA1 P07900 5/20 0.35
HSP90B1 P14625 5/20 0.35
TRAP1 Q12931 5/20 0.35
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
DYRK3 O43781 2/20 0.34
PIM1 P11309 2/20 0.34
DYRK1A Q13627 2/20 0.34
DYRK2 Q92630 2/20 0.34
DYRK1B Q9Y463 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP3A4 P08684 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7501751 0.87 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL6164112 0.82 EDNRA (0.49) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL7505827 0.82 HSP90AA1 (0.39) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL6577515 0.81 KDM4E (0.39) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL6160770 0.79 HSP90AA1 (0.38) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL3838481 0.76 HSP90AA1 (0.37) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL6579996 0.75 HSP90AA1 (0.38) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL27462057 0.75 HSP90AA1 (0.39) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL3834411 0.74 HSP90AA1 (0.42) ALDH1A1SMN1; SMN2KDM4EHPGDEDNRA
SCHEMBL27462058 0.72 TP53 (0.43) ALDH1A1SMN1; SMN2KDM4EHPGDHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0776325-B1 NOVEL USE AND NOVEL DERIVATIVES OF IMIDAZOLE, METHOD FOR PREPARING SAME, NOVEL INTERMEDIATES THUS OBTAINED, MEDICINAL APPLICATIONS OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA SA (FR) 2002-11-20 EP disclosed
US-5932741-A TREATING ILLNESSES RESULTING FROM ABNORMAL STIMULATION OF ENDOTHELIN RECEPTORS HOECHST MARION ROUSSEL (FR) 1999-08-03 US disclosed
US-5811444-A IMIDAZOLE DERIVATIVES ROUSSEL UCLAF (FR) 1998-09-22 US disclosed
EP-0776325-A1 NOVEL USE AND NOVEL DERIVATIVES OF IMIDAZOLE, METHOD FOR PREPARING SAME, NOVEL INTERMEDIATES THUS OBTAINED, MEDICINAL APPLICATIONS OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ROUSSEL UCLAF (FR) 1997-06-04 EP disclosed
WO-1996004276-A1 NOVEL USE AND NOVEL DERIVATIVES OF IMIDAZOLE, METHOD FOR PREPARING SAME, NOVEL INTERMEDIATES THUS OBTAINED, MEDICINAL APPLICATIONS OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ROUSSEL UCLAF (FR) 1996-02-15 WO disclosed